COMMUNIQUÉS West-GlobeNewswire

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
29/04/2026
Ecopipam, Emalex’s investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan Drug and Fast Track designations. The late-stage program in a [...]
Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs
29/04/2026
Eko Vet+ TM | CANINEBEAT ® AI helps veterinarians detect, visualize, and grade heart murmurs in dogs that can otherwise go undetected The CANINEBEAT ® AI algorithm detects heart murmurs associated with structural heart [...]
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
29/04/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (“NDA”) for sovleplenib [...]
Yinuo Chen, fondateur de trois grands centres de procréation assistée – Tulip, ONELIFE et Sino – a été invité à participer à la Shanghai Medical Exhibition
29/04/2026
BICHKEK, Kirghizistan, 29 avr. 2026 (GLOBE NEWSWIRE) -- Yinuo Chen, fondateur de trois grands centres de procréation assistée – Tulip (Kirghizistan), ONELIFE (Thaïlande) et Sino (Géorgie) – a été invité à participer à l [...]
Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
29/04/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel [...]
Phonak Virto ™ R Infinio Earns 2026 Red Dot Award for Product Design
29/04/2026
Recognition highlights precision-crafted customization and next-generation performance in a compact, in-the-ear hearing solution STÄFA, Switzerland, April 29, 2026 (GLOBE NEWSWIRE) -- Phonak, a global leader in [...]
Purespring announces publication of notable study highlighting an under recognised genetic driver of adult-onset FSGS, in particular in US and UK populations
29/04/2026
Population modelling study published in Kidney International Reports Analysis of over 1.2 million genomes from five international databases predicts a substantial, previously underdiagnosed adult NPHS2-FSGS population [...]
AB Science annonce le succès d’un placement prive de 3,2 millions d’euros
29/04/2026
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE DE 3,2 MILLIONS D’EUROS Paris, 29 avril 2026, 8h AB Science S.A. (la “ Société ” ou “ AB Science ”, Euronext – FR0010557264 – AB) annonce aujourd' [...]
AB Science announces the successful completion of a EUR 3.2 million private placement
29/04/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 3.2 MILLION PRIVATE PLACEMENT Paris, April 29, 2026, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces [...]
Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery
29/04/2026
Funding will support commercial deployment, clinical adoption and further development and enhancement of the Hyperspectral Intelligence® platform for AI-assisted surgery Angelini Ventures Managing Director Tanja Dowe [...]
Enlitic Announces Full Integration with Sectra, Expanding Access for Sectra Customers
29/04/2026
LOVELAND, Colo., April 29, 2026 (GLOBE NEWSWIRE) -- Enlitic today announced the completion of its integration with Sectra, enabling Enlitic to support Sectra customers directly with its Ensight platform. The integration [...]
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
29/04/2026
Funds will support one of the largest interventional clinical trials of a full-spectrum microbiome product, and the largest ever to be conducted in IBS Dosing of first patient of the Phase 2b ‘RISE’ trial anticipated in [...]
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
29/04/2026
Greenville, South Carolina, April 28, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) reports that Felix Mirando has resigned as a member of the Company’s Board of Directors for [...]
Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
29/04/2026
MENLO PARK, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (Nasdaq: ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and [...]
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
29/04/2026
BEIJING, April 28, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
29/04/2026
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial [...]
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
28/04/2026
DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for [...]
Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call
28/04/2026
DALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
28/04/2026
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and [...]

Pages